OneMedNet Expands Into $1.5B Healthcare Data Annotation Market With MedCase

Rhea-AI Summary

OneMedNet (Nasdaq:ONMD) has announced a strategic partnership with Medcase to enter the $1.5 billion healthcare data annotation market. The collaboration leverages Medcase's network of 15,000+ healthcare professionals for medical data annotation services, while utilizing OneMedNet's iRWD™ platform and provider network for regulatory-grade, de-identified Real-World Data.

The partnership comes at a strategic time as the market is projected to reach $2.8 billion by 2030. The recent disruption caused by Scale AI's $14.8B investment from Meta has created opportunities for specialized healthcare providers. This collaboration positions OneMedNet to deliver recurring revenue streams by serving healthcare AI developers, pharmaceutical companies, and medical technology leaders.

Positive

• Entry into $1.5B healthcare data annotation market with projected growth to $2.8B by 2030
• Strategic partnership leverages network of 15,000+ healthcare professionals
• Market disruption from Scale AI-Meta deal creates immediate opportunity for specialized providers
• New recurring revenue stream potential in healthcare AI ecosystem

Negative

• Entering a competitive market with established players
• Success dependent on effective integration with Medcase's annotation services

Insights

Business Development Analyst

OneMedNet's partnership with Medcase creates strategic entry into the $1.5B healthcare data annotation market, diversifying revenue streams amid industry disruption.

This partnership represents a strategic market expansion for OneMedNet beyond its core Real-World Data business into the specialized healthcare data annotation sector – currently valued at $1.5 billion and projected to reach $2.8 billion by 2030. The timing is particularly opportune as the announcement highlights a significant market disruption: Scale AI's recent $14.8 billion investment from Meta has reportedly triggered client departures due to competitive intelligence concerns, creating an opening for healthcare-focused specialists.

The partnership's structure creates value in both directions. OneMedNet gains access to Medcase's network of 15,000+ healthcare professionals for annotation services, establishing a new recurring revenue stream complementary to its existing business. Simultaneously, Medcase can leverage OneMedNet's provider network and iRWD™ platform to offer clients regulatory-compliant, de-identified clinical and imaging data – addressing the critical need for privacy-compliant datasets in AI development.

Market conditions appear favorable, with 58% year-over-year headcount growth among healthcare-specific data curation providers indicating strong sector momentum. The partnership positions OneMedNet more centrally in the healthcare data value chain, potentially strengthening its competitive position against generalist data players who lack healthcare-specific expertise and regulatory compliance capabilities.

This expansion represents a logical adjacency that leverages OneMedNet's existing infrastructure and relationships while diversifying revenue streams – particularly important as healthcare emerges as the fastest-growing vertical within the broader data annotation industry. The partnership appears well-aligned with increasing demand for specialized, domain-specific data that meets the unique requirements of healthcare AI development.

MINNEAPOLIS, Sept. 24, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced a strategic partnership with Medcase, a worldwide network of healthcare professionals focused on medical data annotation. This collaboration establishes a new market entry point for OneMedNet and opens a high-growth revenue channel in the healthcare AI ecosystem.

Strategic Expansion into Healthcare Data Annotation

The global healthcare data annotation market, valued at $1.5 billion in 2025 and projected to be $2.8 billion by 2030, has entered a pivotal growth phase¹. Scale AI’s $14.8B investment from Meta has disrupted the industry, triggering an exodus of major clients concerned about competitive intelligence. This shift has created an immediate opportunity for specialized providers focused solely on healthcare—where regulatory compliance, domain expertise, and trust are paramount. With Medcase’s 15,000+ healthcare professionals delivering world-class annotation services, OneMedNet gains a strategic foothold in this fast-growing market, expanding beyond RWD into a complementary and recurring revenue stream.

Leveraging OneMedNet’s Proprietary iRWD™ Platform

In turn, Medcase will leverage OneMedNet’s nationwide provider network and iRWD™ platform to give its clients access to regulatory-grade, de-identified Real-World Data across clinical data including imaging, and EHR data. This combination of high-quality RWD with expert annotation represents a unique competitive advantage for both companies—one that cannot be easily replicated by generalist data players.

High-Growth Market Opportunity

• 58% YoY headcount growth among healthcare-specific data curation providers underscores the market’s acceleration².
• Domain-specific, proprietary data is increasingly the critical differentiator in AI model development.
• Healthcare remains the largest and most regulated opportunity in AI training data, with rising demand for privacy-compliant, longitudinal datasets².
  

“This partnership positions OneMedNet at the center of the healthcare data value chain,” said Aaron Green, CEO & President of OneMedNet. “By combining our iRWD™ platform with Medcase’s annotation expertise, we are extremely well positioned to serve a large unmet market need, unlocking new growth channels that directly strengthen our long-term revenue trajectory.”

“The demand for specialized healthcare annotation is accelerating faster than ever,” said Niv Shochat, CEO of Medcase. “By aligning with OneMedNet, we can now offer our clients access to unparalleled Real-World Data, creating a defensible position in one of AI’s most valuable verticals.”

Positioned for Scale

The global data annotation industry spans multiple enterprise sectors—including automotive, retail, and fintech—but healthcare stands apart as the fastest-growing and most defensible vertical. Together, OneMedNet and Medcase are positioned to deliver recurring, high-margin revenue streams by meeting the unique requirements of healthcare AI developers, pharmaceutical companies, and medical technology leaders.

1. Healthcare Data Collection & Labeling Market Size 2025-2030. (n.d.). - https://www.360iresearch.com/library/intelligence/healthcare-data-collection-labeling
   
2. CB Insights - https://www.cbinsights.com/esp/enterprise-tech/bi-&-operational-intelligence/data-annotation
   

About OneMedNet Corporation

OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.

About MedCase

Medcase Health is a global leader in clinician-led medical data enrichment and healthcare AI services. We connect AI developers, pharmaceutical companies, and medtech leaders with verified health care professionals who deliver precise, specialty-specific labeling across imaging, medical device data, electronic health records and more. Beyond annotation, we provide expert-led audits, FDA-compliant reader studies, and quality oversight to ensure regulatory-grade datasets.

Through collaborations with some of the world’s most prominent technology companies and fast-growing health AI startups, we combine clinical expertise with advanced data enrichment platforms to accelerate model training, improve accuracy, and reduce time to market. With more than 15,000 clinicians worldwide, Medcase enables organizations to scale quickly, meet complex regulatory requirements, and power the next generation of healthcare innovation.

https://www.medcase.health/

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations..

OneMedNet Contacts:
Michael Wong, VP Marketing
Email: michael.wong@onemednet.com

SOURCE: ONEMEDNET CORPORATION

FAQ

What is the value of the healthcare data annotation market that OneMedNet (ONMD) is entering?

The healthcare data annotation market is currently valued at $1.5 billion in 2025 and is projected to grow to $2.8 billion by 2030.

How many healthcare professionals does Medcase bring to the OneMedNet partnership?

Medcase brings a network of over 15,000 healthcare professionals who provide medical data annotation services.

What caused the market opportunity for OneMedNet's expansion into data annotation?

The opportunity arose from Scale AI's $14.8B investment from Meta, which caused major clients to leave due to competitive intelligence concerns, creating space for specialized healthcare providers.

How will OneMedNet's partnership with Medcase generate revenue?

The partnership will generate recurring revenue by providing specialized healthcare data annotation services to AI developers, pharmaceutical companies, and medical technology leaders, while leveraging OneMedNet's iRWD™ platform for regulatory-grade data.

What is the current growth rate in the healthcare data curation provider market?

The market is showing strong growth with a 58% year-over-year headcount growth among healthcare-specific data curation providers.